Trade Apellis Pharmaceuticals, Inc. - APLS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 44.33 |
| Open | 44.05 |
| 1-Year Change | -2% |
| Day's Range | 43.76 - 44.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 45.13 | 0.94 | 2.13% | 44.19 | 45.14 | 42.99 |
| Jun 28, 2022 | 44.33 | -1.68 | -3.65% | 46.01 | 46.49 | 44.24 |
| Jun 27, 2022 | 46.33 | 0.40 | 0.87% | 45.93 | 47.01 | 44.15 |
| Jun 24, 2022 | 46.19 | -1.03 | -2.18% | 47.22 | 47.65 | 44.96 |
| Jun 23, 2022 | 46.89 | 2.96 | 6.74% | 43.93 | 46.97 | 43.60 |
| Jun 22, 2022 | 43.90 | 1.44 | 3.39% | 42.46 | 45.12 | 42.46 |
| Jun 21, 2022 | 43.77 | -0.31 | -0.70% | 44.08 | 45.78 | 43.77 |
| Jun 17, 2022 | 44.05 | 1.60 | 3.77% | 42.45 | 44.94 | 42.45 |
| Jun 16, 2022 | 42.82 | 2.53 | 6.28% | 40.29 | 42.89 | 40.29 |
| Jun 15, 2022 | 41.13 | 3.17 | 8.35% | 37.96 | 41.79 | 37.96 |
| Jun 14, 2022 | 38.79 | -0.40 | -1.02% | 39.19 | 39.51 | 37.67 |
| Jun 13, 2022 | 39.30 | -0.15 | -0.38% | 39.45 | 39.98 | 37.56 |
| Jun 10, 2022 | 41.08 | 1.03 | 2.57% | 40.05 | 41.86 | 40.05 |
| Jun 9, 2022 | 41.65 | -1.31 | -3.05% | 42.96 | 43.48 | 41.37 |
| Jun 8, 2022 | 43.78 | -1.31 | -2.91% | 45.09 | 45.56 | 43.20 |
| Jun 7, 2022 | 45.06 | 3.07 | 7.31% | 41.99 | 45.16 | 41.96 |
| Jun 6, 2022 | 43.12 | -2.57 | -5.62% | 45.69 | 46.96 | 42.71 |
| Jun 3, 2022 | 45.43 | 4.73 | 11.62% | 40.70 | 45.53 | 40.70 |
| Jun 2, 2022 | 42.51 | 2.45 | 6.12% | 40.06 | 43.58 | 40.06 |
| Jun 1, 2022 | 41.30 | -0.10 | -0.24% | 41.40 | 43.33 | 40.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan; and a research collaboration with Beam Therapeutics Inc. focused on the use of Beam''s base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.| Industry: | Biopharmaceuticals |
100 Fifth Avenue
WALTHAM
MASSACHUSETTS 02451
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com